🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

UPDATE 1-Nestle to buy vitamin maker Atrium Innovations for $2.3 bln

Published 2017-12-05, 11:46 a/m
© Reuters.  UPDATE 1-Nestle to buy vitamin maker Atrium Innovations for $2.3 bln
NESN
-

LONDON, Dec 5 (Reuters) - Nestle NESN.S is paying $2.3 billion to buy Canadian vitamin maker Atrium Innovations, it said on Tuesday, expanding its presence in the consumer healthcare market as it seeks to offset weakness in its traditional packaged foods.

The world's largest packaged food company is buying Atrium, which is expected to have 2017 sales of $700 million, from a group of investors led by Permira Funds.

Atrium's largest brand is Garden of Life supplements.

Nestle said the purchase will extend its portfolio with probiotics, plant-based protein nutrition, meal replacements and multivitamins.

This is Nestle's fourth purchase in as many months. It announced deals for Sweet Earth vegetarian foods and Blue Bottle coffee in September and Chameleon Cold-Brew coffee in November.

The purchase is expected to close in the first quarter of 2018.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.